Divergent Progress For Chinese Developers Of COVID Antivirals, Vaccines

Factors Include Demand, New Strains

 
• By Dexter Jie Yan
  
covid therapies hitting FDA wall
Chinese developers of COVID antivirals and vaccines trying hard to tackle mutating coronavirus • Source: Nielsen Hobbs; the Pink Sheet | Shutterstock images
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia